NYSE: HCA

HCA Healthcare (HCA) Stock Analysis & Forecast

Nov 16 close

$511.78+12.73 (+2.6%)

Gekko Brief

AI summaryNov 16 close

HCA Healthcare's recent news flow centers on fund positioning and continued scrutiny of its July 2026 guidance cut. Intech Investment Management reduced its stake by 51.3% in the third quarter, though the same report noted quarterly earnings of $7.22 per share and revenue of $19.85 billion, both ahead of expectations. The JPMorgan Active Value ETF listed HCA as a lead net buy on 11 November. Pomerantz Law Firm disclosed an investigation tied to the payer-mix-driven guidance reduction from July, while HCA also received recognition as a top employer for veterans. An SVP sale of $1.77 million in shares on 10 November followed an earlier stock appreciation rights award.

HCA closed at $511.78, up 2.6%, sitting above both its 50-day average of $454.91 and 200-day average of $445.44, with the shorter average above the longer one, reflecting a supportive trend. The GekkoIndex reads 48.9, placing it in the Neutral zone. Price stands 29.3% above Gekko Fair Value of $395.75, a notable gap.

Over the next 20 trading days, earnings are not due until 26 January 2027, outside this window. Smart-money activity shows one Congressional buy and no sales in the past 90 days. Seasonality over five years shows an average gain of 2.7% across this stretch, rising in 4 of those years. Analyst consensus target sits at $477.27, implying downside of 6.7% from current levels.

Written by AI from the Nov 16, 2026 close and checked automatically against the figures on this page.

HCA Healthcare price vs fair value

$511.78$391.47Nov ’25May ’26Nov ’26
Close $511.78200-day averageGekko Fair Value $391.47

HCA Healthcare quick facts

Market cap
$106.9B
P/E ratio
16.6
Forward P/E
15.9
EPS, TTM
$30.15
Revenue, TTM
$78.70B
Profit margin
8.6%
Dividend yield
0.61%
Beta
1.10
Volume
1.05M avg 1.41M
1-year return
+8.1%
Typical daily move
±3.3%
Typical 20-day move
±6%
50-day average
$454.91
200-day average
$445.44
Next earnings
Jan 26
Shares outstanding
208.9M
52-week range
$353.99$556.52

HCA Healthcare swing-trade checklist

HCA Healthcare scores 4 supportive, 1 mixed and 1 headwind across the 6 checklist items with data.

Six things swing traders check before a 20-day hold, read from the latest data.

4 supportive1 mixed1 headwind

  • Trendsupportive

    Above 50 and 200-day

    Close $511.78 is above the 50-day ($454.91) and 200-day ($445.44) averages, and the 50-day is above the 200-day.

    See the chart
  • GekkoIndexmixed

    48.9, Neutral

    Reading 48.9 is in the Neutral zone.

    See the GekkoIndex
  • Fair valueheadwind

    30.7% above

    Price is 30.7% above Gekko Fair Value (more than 5% above).

    See fair value
  • Smart moneysupportive

    Leans bullish

    Last 90 days: Congress 1 buy / 0 sales.

    See smart money
  • Earnings risksupportive

    Reports in 70 days

    Next report Jan 26, 2027, 70 days away — outside a typical 20-trading-day hold.

    See earnings
  • Seasonalitysupportive

    +1.3% on average

    From this point in the calendar, the next 20 trading days averaged +1.3% over 5 years, rising in 3 of them.

    See seasonality

A description of current data, not a recommendation. How this page works

HCA Healthcare stock chart and price history

HCA Healthcare closed at $511.78 on Nov 16, 2026, +8.1% over the past year, inside a 52-week range of $353.99 to $556.52.

Close50-day average200-day averageVolume
HCA Healthcare share price, past year, with 50-day and 200-day moving averages and volume$400$450$550DecJan 2026FebMarAprMayJunJulAugSepOctNov511.78

Use the left and right arrow keys to read daily values.

Performance Breakdown

1 month
+11.5%
3 months
+24.3%
6 months
+21.0%
1 year
+8.1%
The full HCA chart adds GekkoIndex, insider, options, Congress and hedge fund markers, plus TrendCandles™.Open HCA in Gekko

Follow HCA Healthcare through every session

Put HCA on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.

Track HCA in GekkoFree for 7 days. No credit card required.

About HCA Healthcare

HCA Healthcare provides a wide range of medical services across the United States through its subsidiaries. Its hospitals handle general and acute care, including inpatient treatment, intensive and cardiac care, diagnostics, and emergency medicine, while also supporting outpatient services such as ambulatory surgery, lab work, imaging, respiratory and physical therapy, and cardiology. Beyond hospital campuses, the company runs standalone surgery and emergency centers, urgent care and walk-in clinics, imaging and rehabilitation sites, oncology and radiation facilities, and physician offices.

The company also operates psychiatric hospitals offering treatment for children, adolescents, and adults, along with programs addressing alcohol and drug dependency. Its facilities are grouped into general and acute care hospitals, psychiatric hospitals, and rehabilitation hospitals, supported by a large number of freestanding surgery and endoscopy centers spread across multiple states and England, serving patients who need both hospital-based and outpatient medical care.

HCA Healthcare was founded in 1968 and was previously known as HCA Holdings, Inc. It is headquartered in Nashville, Tennessee, and its shares are listed on the NYSE under the ticker HCA.

Listed
NYSE
Sector
Health services
Industry
Hospital/Nursing management
Website
hcahealthcare.com

HCA Healthcare GekkoIndex: the smart money zone

HCA Healthcare’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 48.9, in the Neutral zone, up 1.9 points over five sessions.

010048.9Neutral

Up 1.9 points over five sessions.

Reading for Nov 16, 2026

What followed past readings in each zone

ZoneReadings5 days10 days20 days50 days
Buying600.0%+0.5%−0.4%+0.3%
Accumulation143+0.4%+0.9%+1.2%+3.4%
Neutral (current zone)435+0.8%+1.1%+1.8%+4.6%
Distribution66−0.6%+0.6%+3.8%+1.7%
Selling3Too few readings yet

Average HCA share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Neutral readings averaged +0.9% over 20 days. Past behaviour doesn’t guarantee future results.

Neutral zone: No clear directional signal. About the five zones →

See every daily GekkoIndex reading plotted over the HCA price, zone by zone.Track HCA in Gekko

Is HCA Healthcare stock overvalued? Gekko Fair Value

HCA Healthcare trades 30.7% above Gekko Fair Value of $391.47, so the shares are overvalued on Gekko’s estimate.

Gekko’s own estimate of what HCA Healthcare shares are worth, recalculated every trading day.

$391.47

Gekko Fair Value, Nov 17, 2026

30.7% Overvalued

At the end of Aug 2026 the price was 4.4% above the estimate.

Gekko Fair ValueShare price, month end
$391$512Aug 2026SepOctNov 2026

How Gekko Fair Value works →

Gekko Fair Value on every chart, with the gap to price updating daily.Open HCA in Gekko

HCA Healthcare insider and Congress trading

No open-market insider purchases were filed for HCA Healthcare, and members of Congress disclosed 1 purchase and 0 sales, in the last 90 days.

Plus buybacks, unusual options and fund positions, each dated to when it became public.

Insider buying last 90 days

No open-market insider purchases were filed for HCA in the last 90 days.

From Form 4 filings, dated to when each was filed.

Every HCA insider filing, plotted on the chart in Gekko.Open HCA in Gekko

Congress trades last 90 days

1trade disclosed: 1 purchase and 0 sales.

MemberTypeAmountDisclosed
Ro Khanna
House, CA, purchase
Purchase$1,001 - $15,000Oct 9
traded Sep 4

From congressional disclosures, which report amounts as ranges.

Buybacks

HCA Healthcare has been buying back its own shares.

Bought back, quarter ended Sep 30, 2026
$2.97B
As a share of market cap
2.78%
Trailing four quarters
$9.16B

From company filings.

Hedge funds and billionaires quarter ended Sep 30

2of the funds Gekko tracks hold HCA.

2added0opened0trimmed0sold out
Which funds are on each side, name by name.Unlock in Gekko

HCA Healthcare earnings: next date and track record

HCA Healthcare reports on Jan 26, 2027 (70 days away), and beat the EPS estimate in 6 of its last 8 reports.

6 of 8reports beat the EPS estimate
±4.4%average move across the report
4 of 8reports followed by a gain

Share-price move across each report

−10.6%Oct ’24+2.0%Jan ’25−2.8%Apr ’25−0.3%Jul ’25+6.3%Oct ’25+4.0%Jan ’26−6.0%Apr ’26+3.5%Jul ’26

Last earnings call, Jul 24, 2026 AI summary

What they said
HCA Healthcare Q2 2026 earnings call focused on payer mix headwinds driven by expiration of enhanced premium tax credits causing exchange patients to migrate to uninsured, leading to significant adjusted EBITDA impact. Management highlighted solid EPS growth (11% quarter and YTD), volume gains in insured populations excluding exchanges, increased uninsured volumes, and incremental net benefit from Medicaid supplemental payment programs, particularly a $540 million benefit from Florida. They emphasized resiliency initiatives to control costs and multi-year investments including $7B capital over 3 years for inpatient and outpatient expansion. Surgery volumes declined (elective down 6%, inpatient emergent stable +2%), professional fees elevated (anesthesia, radiology), and provider taxes affecting other OpEx. Management provided updated guidance reflecting $1.0-1.2B exchange headwind for full year and adjustments for supplemental payments; they expect attrition to be lower in 2027 than 2026 absent new enhanced credits. Risks discussed include payer mix headwinds, Medicaid work requirements, regulatory uncertainties (IDR/no surprises, OPPS proposed rule), and state-specific Medicaid conversion slowdowns (Texas).
Guidance
Company provided forward-looking guidance updates: full-year 2026 updated estimate of exchange headwind of $1.0 billion to $1.2 billion; implied updated full-year adjusted EBITDA guidance reduced by roughly $250 million (management noted ~$500 million reduction after adjustments) aligning to long-term growth algorithm. They also recognized accruals and 21-month Florida Medicaid DPP benefit (10/1/2024-6/30/2026) and included assumed accruals for FY2026 in guidance. Management expects exchange attrition to be less in 2027 than 2026 under assumption that core ACA premium tax credits remain in place.
Risks flagged
Key risks mentioned: expiration of enhanced premium tax credits leading to uninsured migration and unfavorable payer mix; potential further policy or market changes affecting exchanges; Medicaid work requirements implementation uncertainty (esp. in expansion states); state-level Medicaid conversion slowdowns (notably Texas); regulatory and payment uncertainty including IDR/no-surprises adjustments and finalization of OPPS/other CMS rules; dependency on Medicaid supplemental payment program approvals (Florida accrual); inflationary pressures in professional fees (anesthesia, radiology) and provider taxes.
ReportedEPSSurpriseRevenueSurpriseMove
Jul 24, 2026$7.59
est $7.57
+0.3%$20.23B
est $19.76B
+2.4%+3.5%
Apr 24, 2026$7.15
est $7.15
0.0%$19.11B
est $19.09B
+0.1%−6.0%
Jan 27, 2026$8.01
est $7.46
+7.4%$19.51B
est $19.68B
−0.9%+4.0%
Oct 24, 2025$6.96
est $5.79
+20.2%$19.16B
est $18.60B
+3.0%+6.3%
Jul 25, 2025$6.84
est $6.29
+8.7%$18.61B
est $18.50B
+0.6%−0.3%
Apr 25, 2025$6.45
est $5.75
+12.2%$18.32B
est $18.26B
+0.3%−2.8%
Jan 24, 2025$6.22
est $6.14
+1.3%$18.29B
est $18.23B
+0.3%+2.0%
Oct 25, 2024$4.88
est $4.98
−2.0%$17.49B
est $17.54B
−0.3%−10.6%

“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.

HCA Healthcare stock forecast and analyst price targets

Analysts’ average 12-month price target for HCA Healthcare is $483.41, −5.5% from the last close, from 16 firms rating the stock in the last 90 days.

$483.41consensus 12-month target, −5.5% from the last close
Low $380High $570
Buy8
Hold7
Sell1

Each firm’s latest rating in the last 90 days: 16 firms.

Latest analyst actions

DateFirmRatingTargetvs price
Nov 11Mizuho SecuritiesBuy, maintained$570+11.4%
Nov 5Bank of America SecuritiesHold, maintained——
Nov 4BernsteinHold, maintained$471−8.0%
Nov 2Wells FargoHold, maintained$468−8.6%
Oct 29Morgan StanleySell, reiterated$380−25.7%
+1.8%average 20-day move after past Neutral readings
+1.3%average move over the next 20 trading days in the last 5 years
±3.3%typical daily move, from the 14-day average range

Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.

HCA Healthcare seasonality: the next 20 trading days

Over the next 20 trading days from Nov 17, HCA Healthcare averaged +1.3% across the last 5 years, rising in 3 of them.

Next 20 trading days, by year

+4.1%2021+5.2%2022+8.4%2023−8.4%2024−1.5%2025

Average move and hit rate

WindowAverageYears higher
Next 5 trading days+1.1%3 of 5
Next 10 trading days+1.0%3 of 5
Next 15 trading days+1.0%3 of 5
Next 20 trading days+1.3%3 of 5
Next 30 trading days+1.6%3 of 5

For scale, HCA’s typical 20-trading-day move in either direction is about 6%.

HCA Healthcare market cap and key statistics

HCA Healthcare’s market cap is $106.9B, with a P/E ratio of 16.6 and revenue of $78.70B over the last twelve months.

Valuation

Market cap
$106.9B
P/E ratio
16.6
Forward P/E
15.9
EPS, TTM
$30.15
Gekko Fair Value
$391.47

Trading

Volume
1.05M
Avg volume, 20 days
1.41M
52-week high
$556.52
52-week low
$353.99
Shares outstanding
208.9M

Financials

Revenue, TTM
$78.70B
Profit margin
8.6%
Return on equity
136.3%
Quarterly earnings growth, YoY
+4.5%

Risk and income

Beta
1.10
Typical daily move
±3.3%
Typical 20-day move
±6%
Dividend yield
0.61%

HCA Healthcare stock news this week

Coverage of HCA Healthcare this week reads positive: 7 positive, 6 neutral and 2 negative headlines.

News sentiment positive

HCA Healthcare peers

HCA Healthcare’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.

StockTodayGekkoIndex zonevs Fair Value
THCTenet Healthcare+0.5%Neutral1.0% below
UHSUniversal Health Services+0.2%Neutral9.5% below
PACSPACS+1.0%Neutral6.2% below
CHEChemed−0.2%Neutral2.6% below
SGRYSurgery Partners+0.2%Distribution42.5% above
NHCNational HealthCare−0.2%Accumulation18.8% above

A peer links to its own page where one exists.

In the Buying zone today

Reporting earnings this week

Popular on Gekko

More stocks in Hospital/Nursing management

HCA Healthcare stock FAQ

What is HCA Healthcare’s market cap?

HCA Healthcare’s market cap is $106.9B at the Nov 16, 2026 close of $511.78, with 208.9M shares outstanding. The shares trade on a P/E ratio of 16.6.

What is the HCA Healthcare stock forecast?

The consensus analyst 12-month price target for HCA Healthcare is $483.41, −5.5% from the last close. Of the 16 firms that rated the stock in the last 90 days, 8 rate it a buy, 7 a hold and 1 a sell. Gekko doesn’t publish price predictions of its own.

Is HCA Healthcare stock overvalued or undervalued?

On Gekko’s estimate HCA Healthcare is overvalued: the Nov 16, 2026 close of $511.78 is 30.7% above Gekko Fair Value of $391.47. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.

When does HCA Healthcare report earnings next?

HCA Healthcare is expected to report on Jan 26, 2027 (70 days away). Analysts expect earnings of $8.17 per share on revenue of $20.02B. HCA Healthcare beat the earnings estimate in 6 of its last 8 reports, moving 4.4% on average across the report.

What is HCA Healthcare’s 52-week high and low?

HCA Healthcare’s 52-week high is $556.52 and its 52-week low is $353.99; it closed at $511.78 on Nov 16, 2026, +8.1% over the past year.

Is HCA Healthcare stock a buy right now?

Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 4 of the 6 items with data read as supportive (trend, smart money, earnings risk and seasonality), 1 as mixed (gekkoindex) and 1 as a headwind (fair value). The checklist is a description of current data, not a recommendation.

How this page works

During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →

See HCA Healthcare the way Gekko members do

Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.

Join 1,476 other traders using Gekko

Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.